CLINICAL_TRIALS trial_result · 2017-12-06

Clinical Trial Update: Dose-Ranging Study in Treatment Naive Type 2 Diabetes Mellitus(T2DM) [Phase 2]

Phase 2 dose-ranging study in treatment-naive type 2 diabetes mellitus has completed enrollment and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: GlaxoSmithKline | Conditions: Diabetes Mellitus, Type 2 | Phase 2 | Status: COMPLETED | Results posted: 2017-12-06